BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1233223)

  • 21. Plasma protein binding of diazepam and tolbutamide in chronic alcoholics.
    Thiessen JJ; Sellers EM; Denbeigh P; Dolman L
    J Clin Pharmacol; 1976 Jul; 16(7):345-51. PubMed ID: 947967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of acute renal failure on the protein binding of drugs in animals and in man.
    Belpaire FM; Bogaert MG; Mussche MM
    Eur J Clin Pharmacol; 1977; 11(1):27-32. PubMed ID: 832654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma protein binding of drugs in pregnancy.
    Perucca E; Crema A
    Clin Pharmacokinet; 1982; 7(4):336-52. PubMed ID: 6749369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of age and sex on the plasma binding of acidic and basic drugs.
    Verbeeck RK; Cardinal JA; Wallace SM
    Eur J Clin Pharmacol; 1984; 27(1):91-7. PubMed ID: 6489431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the distribution of drugs in saliva and blood plasma.
    Feller K; le Petit G
    Int J Clin Pharmacol Biopharm; 1977 Oct; 15(10):468-9. PubMed ID: 21854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of smoking on serum protein composition and the protein binding of drugs.
    Benedek IH; Blouin RA; McNamara PJ
    J Pharm Pharmacol; 1984 Mar; 36(3):214-6. PubMed ID: 6144765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microultrafiltration technique for drug-protein binding determination in plasma.
    Shah VP; Wallace SM; Riegelman S
    J Pharm Sci; 1974 Sep; 63(9):1364-7. PubMed ID: 4427256
    [No Abstract]   [Full Text] [Related]  

  • 28. The influence of increased plasma protein binding on the disposition of quinidine in turpentine-treated rats.
    Sugihara N; Furuno K; Kita N; Murakami T; Yata N
    Biol Pharm Bull; 1993 Jan; 16(1):63-7. PubMed ID: 8369755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The binding of drugs to plasma proteins from patients with poor renal function.
    Reidenberg MM
    Clin Pharmacokinet; 1976; 1(2):121-5. PubMed ID: 797494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma protein binding of salicylate and quinidine in patients with multiple myeloma.
    Perez-Mateo M; Erill S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):168-70. PubMed ID: 447437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug protein binding and the nephrotic syndrome.
    Gugler R; Azarnoff DL
    Clin Pharmacokinet; 1976; 1(1):25-35. PubMed ID: 797490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum protein binding of drugs and bilirubin in newborn infants and their mothers.
    Hamar C; Levy G
    Clin Pharmacol Ther; 1980 Jul; 28(1):58-63. PubMed ID: 7389254
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical utility of free drug monitoring.
    Dasgupta A
    Clin Chem Lab Med; 2002 Oct; 40(10):986-93. PubMed ID: 12476936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in the binding of quinine and quinidine to plasma proteins.
    Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
    Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in the binding of drugs to plasma proteins from newborn and adult man. I.
    Kurz H; Mauser-Ganshorn A; Stickel HH
    Eur J Clin Pharmacol; 1977 Jul; 11(6):463-7. PubMed ID: 891592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uraemic patients.
    Ehrnebo M; Odar-Cederlöf I
    Eur J Clin Pharmacol; 1975 Aug; 8(6):445-53. PubMed ID: 1233247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma binding of fluorescein in normal subjects and in diabetic patients.
    Palestine AG; Brubaker RF
    Arch Ophthalmol; 1982 Jul; 100(7):1160-1. PubMed ID: 7092661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug protein binding in chronic renal failure: evaluation of nine drugs.
    Vanholder R; Van Landschoot N; De Smet R; Schoots A; Ringoir S
    Kidney Int; 1988 May; 33(5):996-1004. PubMed ID: 3392889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of quinidine related to plasma protein binding in man.
    Fremstad D; Nilsen OG; Storstein L; Amlie J; Jacobsen S
    Eur J Clin Pharmacol; 1979 Apr; 15(3):187-92. PubMed ID: 456401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative Estimation of Plasma Free Drug Fraction in Patients With Varying Degrees of Hepatic Impairment: A Methodological Evaluation.
    Li GF; Yu G; Li Y; Zheng Y; Zheng QS; Derendorf H
    J Pharm Sci; 2018 Jul; 107(7):1948-1956. PubMed ID: 29518400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.